ArticleOncotarget2018

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging.

Meiko Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.